CRISIL Issues Monitoring Agency Report for GSP Crop Science's IPO Proceeds
GSP Crop Science Ltd · Others (Uncategorized) · 14 Nov 2026, 3:20 am
CRISIL Issues Monitoring Agency Report for GSP Crop Science's IPO Proceeds CRISIL Ratings released its Monitoring Agency Report for GSP Crop Science for the quarter ended 30th Sep'26, confirming zero deviation from stated IPO objects. Out of total gross fresh issue proceeds of ₹2,400.00 mn, the company utilized ₹2,382.19 mn by quarter-end, including ₹1,700.00 mn for debt repayment/prepayment, ₹503.17 mn for general corporate purposes, and ₹179.02 mn toward issue expenses (₹2.56 mn spent during the quarter). An unutilized balance of ₹17.81 mn remains deployed in the company's public issue bank account.
Original exchange filing (PDF)
More announcements from GSP Crop Science Ltd
- Audio recording of the Earnings Conference Call held with analysts/investors in relation to the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. · 16 Nov 2026
- Investor presentation on Q2 and H1 FY2027. · 14 Nov 2026
- Press Release on Financial Performance of the Company for the Quarter and Half year ended September 30, 2026. · 14 Nov 2026
- GSP Crop Science Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 14 Nov 2026
- GSP Crop Science Limited has informed the Exchange regarding change in Corporate Office of the company. · 14 Nov 2026
- GSP Crop Science Limited has informed the Exchange about Retirement of Mr. Rajesh Valiya Naduvath-Head of International Business and Strategy of the Company from the services of the Company with effect from November 13, 2026 and consequently ceased to be Senior Management Personnel (SMP) of the Company. · 14 Nov 2026
- GSP Crop Science Limited has informed the Exchange regarding Appointment of Mr. Shail Jayesh Shah as Chief Financial Officer of the company w.e.f. November 13, 2026, and re-designated as Executive Director-Finance and CFO. · 14 Nov 2026
- Statement of No Deviation(s) or Variation(s) of the IPO Proceeds of the Company for the quarter ended September 30, 2026. · 14 Nov 2026
